OCT 13, 2016 06:00 AM PDT
Just Released! Pediatric Venous Thromboembolism Screening, Diagnosis and Treatment: Current Status and Breaking Research
Presented at the Stago EdVantage Virtual University Virtual Event
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE | Florida CE
2 14 1064

Speakers:
  • Associate Professor of Pediatrics, University of Toronto, Hemostasis and Thrombosis Service, The Hospital for Sick Children
    Biography
      Dr. Leonardo Brandao is a native Brazilian who obtained his medical degree at University of Sao Paulo (USP). After doing post-graduate training at the same institution, he pursued training in North America in Pediatrics (Emory University, Atlanta, Georgia), Pediatric Hematology/Oncology (St. Jude Children's Research Hospital, Memphis, Tennessee) and Pediatric Coagulation (Weill Cornell University, New York, New York). In brief, his North American training initially included a fellowship at St. Jude's Children's Research Hospital, where he was actively involved in studying clinical coagulation laboratory tools in children with acute lymphoid leukemia, as well as working in a gene therapy laboratory to study the expression of antithrombin by different cell lines. This was followed by training in pediatrics/coagulation (Emory University), where he developed and coordinated research projects on bleeding (pediatric bleeding score, platelet function defects). During his second fellowship training at Weill Cornell University, his research was solely focused on pediatric coagulation, in the management of both bleeding (new laboratory tools for phenotype definition in hemophilia) and thrombosis (the role of inherited thrombophilia in venous thrombosis) in children. He is currently a staff member with the Hemostasis and Thrombosis Service. This is Canada's largest referral based-tertiary hospital. Because of its' privileged position in the field of pediatric thrombosis, Sickkids® continues to be instrumental in the development of the field of pediatric thrombosis, by participating in several dose finding studies for several of the new anticoagulants in children, as well as other prospective clinical research studies (i.e. perfusion medicine, cardiology, pediatric thrombosis). Dr. Brandao is also actively involved in the field of coagulation in children with congenital heart defects, in the area of long-term thrombosis outcome (i.e. post-thrombotic syndrome), and in the subject of coagulation derangements in children with vascular anomalies.

    Abstract:


    Just Released On Demand Webinar in Honor of World Thrombosis Day!



    VTE is a serious hypercoagulable disorder with significant risk of morbidity and mortality and an incidence of 188 per 100,000 children discharged from hospitals in the United States (approximately 4,500 total) according to one study (Setty et al., Pediatr Blood Cancer 2012).  While diagnostic and treatment guidelines are well established for adult populations, less published information has typically been available for practitioners responsible for working with pediatric populations.  In order to provide needed clarification, this webinar will provide an overview of current literature and known best practices for screening, confirmation, and diagnosis of pediatric VTE.  

    Objectives:
    • Explain overview of the venous thromboembolism (VTE) disease state and presentation in at risk pediatric populations.
    •  Clarify screening algorithms for pediatric VTE diagnosis.
    •  Present current treatment options for pediatric populations diagnosed with VTE.
    •  Discuss research studies previously published or in development which allows for improvement of best practices for patients presenting with this disorder.
    This webinar is available on-demand, 24/7 starting on October 13 at 6 am PT at no cost!  Simply preregister to schedule the webinar on your calendar then login any time after that date and time to view the webinar alone or with colleagues.

     

    Show Resources
    Loading Comments...